Keck School gets new director of Kidney Research Center

Kenneth Hallows, MD, PhD

Kenneth R. Hallows is the new chief of the Division of Nephrology and director of the USC/UKRO Kidney Research Center.

A pioneering physician has joined the Keck School of Medicine of USC as chief of the Division of Nephrology and director of the USC/UKRO Kidney Research Center.

Kenneth R. Hallows, MD, PhD, is an internationally recognized expert in ion transport physiology and in transport-metabolism coupling via the metabolic sensor AMP-activated protein kinase, an enzyme that plays a role in cellular energy homeostasis.

His clinical interests include electrolyte disorders, acute kidney injury and polycystic kidney disease.

“We are delighted that Ken has agreed to join USC,” said Edward Crandall, MD, chair of the Department of Medicine. “He is an excellent scientist with outstanding credentials, and we expect he will lead the division and the Kidney Research Center to world-class status.”

Hallows graduated with a degree in biophysics in 1987 from Brown University. He was then recruited to the MD-PhD program at the University of Rochester School of Medicine in New York, earning his PhD in biophysics in 1993 and his MD in 1995.

Hallows’ goal as director of the kidney center will be to establish a research team that interacts well with the strengths of the university, fostering collaborations with experts with complementary skills and promoting research by faculty members in a challenging funding climate. He will seek out talented recruits with an eye toward synergy and will promote translational projects that bridge basic science and clinical research.

Hallows plans to broaden his own experimental repertoire toward in vivo and human studies that utilize conditional and tissue-specific transgenic mouse models and clinical patient-centered studies in kidney disease.

“I envision that the Division of Nephrology will become a center of excellence in basic and translational kidney research with clinical initiatives that have a direct positive impact on patients with kidney disease in Los Angeles and nationwide,” Hallows said.

Hallows’ recruitment is expected to increase visibility of the division nationally through increased research and publications in national journals, as well as an expansion of faculty leadership and committee participation in national organizations.

By Douglas Morino